Breast/ovarian cancer
101 – 110 of 143
                - show: 10
 - |
 - sort: year (new to old)
 
        Close
        
            
    
        Embed this list
<iframe src=""
              width=""
              height=""
              allowtransparency="true"
              frameborder="0">
            </iframe>
        - 2020
 - 
                        Mark
        SOX2 is a promising predictor of relapse and death in advanced stage high-grade serous ovarian cancer patients with residual disease after debulking surgery
    
    
- Contribution to journal › Article
 
 - 
                        Mark
        The mutational landscape of the SCAN‐B real‐world primary breast cancer transcriptome
    
    
- Contribution to journal › Article
 
 - 
                        Mark
        Auto-segmentations by convolutional neural network in cervical and anorectal cancer with clinical structure sets as the ground truth
    
    
- Contribution to journal › Article
 
 - 
                        Mark
        Human G-MDSCs are neutrophils at distinct maturation stages promoting tumor growth in breast cancer
    
    
- Contribution to journal › Article
 
 - 
                        Mark
        CYP27A1 expression is associated with risk of late lethal estrogen receptor-positive breast cancer in postmenopausal patients
    
    
- Contribution to journal › Article
 
 - 
                        Mark
        Simvastatin is a potential candidate drug in ovarian clear cell carcinomas
    
    
- Contribution to journal › Article
 
 - 
                        Mark
        A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients
    
    
- Contribution to journal › Article
 
 - 
                        Mark
        Defining the mutational landscape of 3,217 primary breast cancer transcriptomes through large-scale RNA-seq within the Sweden Cancerome Analysis Network: Breast Project (SCAN-B; NCT03430492).
    
    
- Contribution to journal › Published meeting abstract
 
 - 
                        Mark
        Prognostic implications of the expression levels of different immunoglobulin heavy chain-encoding RNAs in early breast cancer
    
    
- Contribution to journal › Article
 
 - 
                        Mark
        Comprehensive molecular comparison of BRCA1 hypermethylated and BRCA1 mutated triple negative breast cancers
    
    
- Contribution to journal › Article
 
 
